Asarina Pharma (Sweden) Today

ASAP Stock  SEK 0.96  0.01  1.05%   

Performance

3 of 100

 
Low
 
High
Insignificant

Odds Of Distress

Over 77

 
100  
 
Zero
High
Asarina Pharma is selling for under 0.96 as of the 28th of March 2024; that is 1.05 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.96. Asarina Pharma has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Asarina Pharma AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of April 2022 and ending today, the 28th of March 2024. Click here to learn more.
Asarina Pharma AB , a research and development company, focuses on developing pharmaceutical products to treat diseases associated with menstrual cycle. Asarina Pharma AB was incorporated in 2005 and is based in Solna, Sweden. Asarina Pharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 22.64 M outstanding shares. More on Asarina Pharma AB

Moving against Asarina Stock

  0.67ATCO-A Atlas Copco ABPairCorr
  0.58XSPRAY XSpray Pharma ABPairCorr
  0.57VOLV-A AB VolvoPairCorr
  0.56VOLV-B AB VolvoPairCorr
  0.52VITR Vitrolife ABPairCorr
  0.49ALIV-SDB AutolivPairCorr
  0.42ASSA-B ASSA ABLOY ABPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Asarina Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Asarina Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Asarina Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
Asarina Pharma AB (ASAP) is traded on Stockholm Exchange in Sweden and employs 2 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 29.61 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Asarina Pharma's market, we take the total number of its shares issued and multiply it by Asarina Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Asarina Pharma AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 22.64 M outstanding shares. Asarina Pharma AB has accumulated about 21.71 M in cash with (42.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Asarina Pharma Probability Of Bankruptcy
Ownership Allocation
Asarina Pharma holds a total of 22.64 Million outstanding shares. Asarina Pharma AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Asarina Ownership Details

Asarina Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Asarina Pharma jumping above the current price in 90 days from now is about 60.75%. The Asarina Pharma AB probability density function shows the probability of Asarina Pharma stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 1.1664. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Asarina Pharma will likely underperform. Additionally, asarina Pharma AB has an alpha of 0.2022, implying that it can generate a 0.2 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 0.96HorizonTargetOdds Above 0.96
39.12%90 days
 0.96 
60.75%
Based on a normal probability distribution, the odds of Asarina Pharma to move above the current price in 90 days from now is about 60.75 (This Asarina Pharma AB probability density function shows the probability of Asarina Stock to fall within a particular range of prices over 90 days) .

Asarina Pharma AB Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Asarina Pharma market risk premium is the additional return an investor will receive from holding Asarina Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Asarina Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Asarina Pharma's alpha and beta are two of the key measurements used to evaluate Asarina Pharma's performance over the market, the standard measures of volatility play an important role as well.

Asarina Stock Against Markets

Picking the right benchmark for Asarina Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Asarina Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Asarina Pharma is critical whether you are bullish or bearish towards Asarina Pharma AB at a given time. Please also check how Asarina Pharma's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Asarina Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bonds Directory Now

   

Bonds Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Asarina Pharma Corporate Management

Elected by the shareholders, the Asarina Pharma's board of directors comprises two types of representatives: Asarina Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Asarina. The board's role is to monitor Asarina Pharma's management team and ensure that shareholders' interests are well served. Asarina Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Asarina Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Otto MScChief OfficerProfile
Torbjrn MDChief BoardProfile
Peter NordkildCEO OfficerProfile
MBA MScChief OfficerProfile
Mark DuBoisCommunications MangProfile
Karin EkbergChief OfficerProfile

How to buy Asarina Stock?

Before investing in Asarina Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Asarina Pharma. To buy Asarina Pharma stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Asarina Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Asarina Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Asarina Pharma AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Asarina Pharma AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Asarina Pharma AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Asarina Pharma AB?

The danger of trading Asarina Pharma AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Asarina Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Asarina Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Asarina Pharma AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Asarina Pharma AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Asarina Stock analysis

When running Asarina Pharma's price analysis, check to measure Asarina Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Asarina Pharma is operating at the current time. Most of Asarina Pharma's value examination focuses on studying past and present price action to predict the probability of Asarina Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Asarina Pharma's price. Additionally, you may evaluate how the addition of Asarina Pharma to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Please note, there is a significant difference between Asarina Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Asarina Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Asarina Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.